Patient and Provider Perspectives on Genetic Risk Profiling
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 18 lat lub starsi
- •Pacjenci, którzy przeszli test genetyczny na ryzyko raka prostaty i otrzymali wyniki
- •Osoby z różnym pochodzeniem, wiekiem i statusem ryzyka
- •Lekarze, którzy przekazywali pacjentom wyniki testów genetycznych na raka prostaty
✗ Disqualifies
- •Osoby niemające zdolności do podania świadomej zgody
- •Osoby w złym stanie ogólnym lub z poważnymi problemami zdrowotnymi
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 100 Years
- Last updated (source)
- August 3, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
The Royal Marsden Hospital (Sutton and Chelsea)
London, United Kingdom
Trial contact
Tarryn Shaw, MSc
Elizabeth Bancroft, RN PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/4/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.